Recombinant VEGF (Bevacizumab Biosimilar) antibody

Catalog No. ABIN7487772

The Mammalian Cells Monoclonal anti-VEGF (Bevacizumab Biosimilar) antibody has been validated for . It is suitable to detect VEGF (Bevacizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant VEGF (Bevacizumab Biosimilar) antibody (ABIN7487772)

Target: VEGF (Bevacizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This VEGF (Bevacizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-VEGF (Bevacizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Bevacizumab Biosimilar - Anti-VEGF mAb

Characteristics: Antibody Type: IgG1

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1, IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer pH 7.5

Storage: 4 °C,-20 °C

Storage Comment: 4°C for short term, -20°C for long term

Target Details for VEGF (Bevacizumab Biosimilar)

Target: VEGF (Bevacizumab Biosimilar)

Target Type: Biosimilar

Background: Bevacizumab